These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10975069)

  • 1. Evolution of drugs that preserve renal function.
    Basta E; Bakris GL
    J Clin Pharmacol; 2000 Sep; 40(9):978-89. PubMed ID: 10975069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE; Ruilope LM; Barnett AH
    J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection.
    Locatelli F; Del Vecchio L; Andrulli S; Colzani S
    Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?
    Weir MR
    Curr Hypertens Rep; 2000 Dec; 2(6):497-9. PubMed ID: 11062593
    [No Abstract]   [Full Text] [Related]  

  • 9. Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels?
    Mulrow CD; Townsend RR
    Ann Intern Med; 2003 Aug; 139(4):296-8. PubMed ID: 12965986
    [No Abstract]   [Full Text] [Related]  

  • 10. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. Blood pressure and urine protein levels with the least risk for worsening kidney disease.
    Ann Intern Med; 2003 Aug; 139(4):I36. PubMed ID: 12965997
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Jafar TH; Stark PC; Schmid CH; Landa M; Maschio G; de Jong PE; de Zeeuw D; Shahinfar S; Toto R; Levey AS;
    Ann Intern Med; 2003 Aug; 139(4):244-52. PubMed ID: 12965979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers in the prevention of end stage renal disease: a review.
    Derwa A; Peeters P; Vanholder R
    Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
    Kaperonis N; Bakris G
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):79-84. PubMed ID: 12496670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.
    Doleželová Š; Jíchová Š; Husková Z; Vojtíšková A; Kujal P; Hošková L; Kautzner J; Sadowski J; Červenka L; Kopkan L
    Clin Exp Hypertens; 2016; 38(7):644-651. PubMed ID: 27669111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.